by bureau Peppr | 20 May, 2025 | News
Oss, NL May 20, 2025 BioConnection is pleased to announce the appointment of Mireille Sanders as member of our Supervisory Board. She succeeds Sijmen de Vries at this position who steps back at the same time. We are happy that Ms. Sanders continues this position on...
by bureau Peppr | 16 April, 2025 | News
BioConnection and Prestige Biologics We noticed that various channels shared information about the legal proceedings between BioConnection B.V. and Prestige Biologics Co. Limited: On 11 March 2025, the Dutch court ruled in favor of BioConnection in an inspection...
by bureau Peppr | 17 January, 2025 | News
Successful IGJ inspection completed We are proud to share that last week BioConnection successfully completed a three-day inspection by the Healthcare and Youth Inspectorate (IGJ), conducted on behalf of the European Medicines Agency (EMA). This result confirms our...
by bureau Peppr | 7 October, 2024 | News
BioConnection Receives European CMO of the Year Award 2024 in (Bio)pharmaceuticals BioConnection is excited to share that we’ve been named the European Company of the Year in Biopharmaceutical Contract Manufacturing 2024 by Pharma Tech Outlook. This award means a...
by bureau Peppr | 2 September, 2024 | News
Oss, NL September 2, 2024 We are excited to announce that Richard Sewalt has joined BioConnection as our new Chief Commercial Officer (CCO). With his extensive background and proven expertise, Richard will be a key driver of our continued success and growth. Richard...
